Migdal Insurance & Financial Holdings Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.97 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$472.8 - $558.54 $650,572 - $768,551	-1,376 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$446.73 - $548.2 $384,187 - $471,452	860 Added 166.67%	1,376 $651,000
Q4 2020 Feb 08, 2021	BUY	$478.3 - $607.98 $246,802 - $313,717	516 New	516 $249,000
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $185,708 - $222,881	-553 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$351.14 - $408.51 $115,173 - $133,991	328 Added 145.78%	553 $223,000
Q2 2018 Aug 01, 2018	BUY	$284.6 - $344.99 $62,042 - $75,207	218 Added 3114.29%	225 $78,000
Q1 2018 May 02, 2018	BUY	$315.82 - $393.78 $2,210 - $2,756	7 New	7 $2,000

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

9.29M
Shares

$6.62 Billion
0.12% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$6.02 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

7.06M
Shares

$5.04 Billion
0.41% of portfolio
State Street Corp Boston, MA

4.83M
Shares

$3.45 Billion
0.14% of portfolio
Capital International Investors Los Angeles, CA

4.74M
Shares

$3.38 Billion
0.66% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account